Panafic Industrials Other Announcement
Panafic reports full utilisation of Rs.41.06 crore rights issue proceeds with nil deviation. This is the final Monitoring Agency Report for the quarter ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Every other announcement announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
10,434 announcements with these filters
Panafic reports full utilisation of Rs.41.06 crore rights issue proceeds with nil deviation. This is the final Monitoring Agency Report for the quarter ended September 30, 2026.
LAPL Automotive reports no deviation in IPO fund utilisation for the half year to September 2026. Rs.1,956 lakh of the Rs.3,239.62 lakh proceeds remains unutilised.
Capitalnumbers Infotech's Reg 32 statement shows Rs 4,339.73 lakh of IPO proceeds utilised and Rs 4,128.87 lakh unutilised. Allocations were revised by shareholder resolution.
Caliber Mining filed CARE Ratings' monitoring report on IPO proceeds for July to September 2026. The report records no deviation from the stated objects of the issue.
Kaushalya Logistics submitted its half-yearly related party transactions disclosure for the period ended September 30, 2026. Figures are not stated in the letter.
Kshitij Polyline's monitoring agency report shows no deviation in rights-issue fund use for the quarter ended September 30, 2026. The issue was revised down to ₹18.98 crore.
RHI Magnesita India announced Abhishek Bajaj's appointment as CFO and Chief Investor Relations Officer, effective January 1, 2027. He is a chartered accountant with two decades' experience.
Shivchem Agro Limited told BSE that its Reg 32 statement of deviation on IPO proceeds is not applicable for the half year ended September 30, 2026. The company's equity shares listed on the BSE SME Platform on October 6, 2026.
Ikoma Technologies will miss the November 14, 2026 deadline for Q2 and half-year unaudited results. It will convene a board meeting at the earliest possible date.
Orchid Pharma's QIP monitoring report for the quarter ended September 2026 shows no deviation from objects. It flags revised fund allocation and delayed Jammu facility commercial operations.
Manipal Health Enterprises submitted CARE Ratings' monitoring agency report for the quarter ended September 30, 2026. It reports nil deviation from the IPO objects.
Apana Logistics filed its Reg 32 statement of IPO fund utilisation for the quarter ended 30 September 2026. No deviation or variation in utilisation was reported.
NCL Research & Financial Services filed its Reg 32 statement for the quarter ended September 30, 2026. It reports no deviation or variation in use of rights issue proceeds.
Z-Tech filed its Reg 32 statement for the quarter ended 30.09.2026 on preferential warrant proceeds. No deviation or variation in utilisation of funds was reported.
Shri Ahimsa Naturals filed its IPO proceeds monitoring report for the quarter ended September 30, 2026. It flags a deviation of about Rs.44,000 in pre-operative charges.
Kalyani Cast-Tech reported no deviation in using warrant issue proceeds for the half year ended September 2026. This routine Regulation 32 statement involves no new transaction.
Telogica filed its half-yearly related party transactions disclosure for the period ended 30 September 2026. This is routine Regulation 23(9) compliance reporting, not a new transaction.
Ducol Organics filed its half-year IPO proceeds utilisation statement with an auditor certificate. It reports no deviation from stated objects, making this a Reg 32 compliance filing.
Godawari Power & Ispat unveiled a new corporate logo and brand identity at its Q2 board meeting. The rebrand unifies the group under the 'ONE Godawari' vision.
Innovision changed its accounting estimate for NHAI toll fee recognition from straight-line to traffic-based, effective 1 July 2026. It alters expense timing, not total fees.
Raaj Medisafe filed its Reg 32 statement on preferential issue proceeds for the quarter ended September 2026. No deviation in fund use is reported.
Italian Edibles reports no IPO fund deviation for the half year to September 2026. Project cost rose to Rs 2,300 lakhs; IPO proceeds temporarily shifted across sub-heads.
Porwal Auto's statement confirms no deviation in preferential issue fund use for the quarter ended September 30, 2026. The filing reports Rs 577.03 lakh utilised.
DCM Limited named three officials, including the MD, authorised to determine materiality of events under Regulation 30(5). The authorisation takes effect from 16 November 2026.
Systematix filed a monitoring agency report on its preferential issue proceeds for the quarter ended September 2026. The report found no deviation from offer objects.
Sarthak Global Limited filed a notice that it is exempt from Regulation 23(9) related party transaction disclosures under Regulation 15(2). The exemption applies because its paid-up capital and net worth are below Rs 10 Crore and Rs 25 Crore.
Nagarjuna Fertilizers delays September 2026 quarter results to December 1, 2026. Company cites no new cash flows and unpaid salaries, utilities and rents.
Gini Silk Mills filed its FY2026 Secretarial Compliance Report under Regulation 24A. The report records no non-compliances, fines or regulatory actions.
Technocrats Plasma filed its IPO monitoring agency report for quarter ended 30 September 2026. Rs.26.85 crore of Rs.60.98 crore raised is utilised, with no deviation.
Gufic Biosciences disclosed an ESG rating of 69.7/100 (Medium) for FY 2025-26, assigned by SES ESG Research on its own initiative. The company did not engage the rating provider.